Ellen and Ronald Caplan Cancer Center
-
Wistar Institute, Temple Scientists Identify Metabolic Target To Overcome Chemotherapy Resistance in Ovarian Cancer
Many cancers can be treated by administering DNA-damaging agents, such as platinum-based chemotherapy, because the resulting DNA damage causes the cancer cells to die. A…
-
Researchers from Wistar Institute, ChristianaCare Identify Promising New Therapeutic Target for Pancreatic Cancer
Scientists at The Wistar Institute and clinical researchers from ChristianaCare’s Helen F. Graham Cancer Center & Research Institute have discovered a vulnerability in pancreatic cancer that could…
-
The Wistar Institute Announces Dr. Dario Altieri Leadership Transition
The Wistar Institute, a biomedical research leader in cancer, immunology and infectious disease, announces Dario C. Altieri, M.D., Wistar’s president and CEO, director of the Ellen and…
-
Wistar Institute Receives Exceptional Rating in Renewal of its Cancer Center Support Grant
The National Cancer Institute (NCI) rated The Wistar Institute’s Ellen and Ronald Caplan Cancer Center as “exceptional” for the third time in a row during the renewal of…
-
The Wistar Institute Appoints Two New Members to its Board of Trustees
The Wistar Institute, a global leader in biomedical research in cancer, immunology and infectious disease, is pleased to welcome two new members to its Board…
-
Wistar to Honor Dr. Svetlana Mojsov Whose Discovery of GLP-1 Protein is Behind Blockbuster Weight-Loss Drugs
The Wistar Institute honors Svetlana Mosjov, Ph.D., as the 2025 Helen Dean King Award recipient. Dr. Mojsov, research associate professor at the Rockefeller University, is…
-
Wistar Scientists Discover p53 Can “Read” Cellular Signals to Direct Immune Response
Wistar Institute researchers have overturned three decades of scientific thinking about p53, the most important tumor suppressor protein in cancer research. In a study published…
-
Wistar Institute Launches Center for Advanced Therapeutics to Accelerate Scientific Innovation into Future Medicines
The Wistar Institute announces the opening of its new Center for Advanced Therapeutics (CAT) to harness the power of Wistar science and speed creation of…
-
Wistar Institute Appoints Katherine Aird, Ph.D., to Ellen and Ronald Caplan Cancer Center
The Wistar Institute, an international biomedical research leader in cancer, immunology and infectious diseases, has announced the appointment of Katherine Aird, Ph.D., as co-leader and professor…
Founding Partners
Advertisement
Affiliate Partners
